You are here: Industry Insights > Medicine

News List

Medicine shortages should be an industry priority, EFPIA says europeanpharmaceuticalreview
January 19, 2020
The European Federation of Pharmaceutical Industries and Associations (EFPIA) has said that medicine shortages may negatively impact patient care and deserves serious action.
US study investigates how medicines can be removed from wastewater europeanpharmaceuticalreview
January 13, 2020
New research has shown that technologies are available for US treatment plants to remove medicines from wastewater but that upgrades can be expensive.
The Advance Value Framework: evaluating the benefits of novel medicines europeanpharmaceuticalreview
January 09, 2020
Researchers have proven their methodology for drug benefit evaluation to be effective as a decision support tool in a study with several European drug evaluation bodies.
Sandoz announces global deal to commercialize proposed biosimilar natalizumab, a key multiple sclerosis medicine worldpharmanews
September 06, 2019
Sandoz, a Novartis division and a global leader in biosimilars, announced that it has entered into a global commercialization agreement for a proposed natalizumab biosimilar.
Merck Grant to Support Smithsonian Future Exhibition on History of American Medicine americanpharmaceuticalreview
September 04, 2019
Merck recently awarded a $500,000 grant to the Smithsonian’s National Museum of American History to use for developing an exhibition and programming on the history of American medicine in recognition of ...
Insilico Medicine develops new AI drug discovery system pharmaceutical-technology
September 04, 2019
Insilico Medicine has developed an artificial intelligence (AI)-powered system to facilitate the creation of therapeutic molecules.
FDA and EMA align on 90 percent of marketing authorisation decisions europeanpharmaceuticalreview
August 23, 2019
A study has found that between 2014 and 2016, the EMA and FDA had very little divergence in their marketing authorisation decisions.
Roche's first FDA-approved tumour-agnostic medicine worldpharmanews
August 19, 2019
Roche announced that the US Food and Drug Administration (FDA) has approved Rozlytrek™ (entrectinib) for the treatment of adults with ROS1-positive, metastatic non-small cell lung cancer (NSCLC).
Medicare Spending on Essential Medicines Up 116 Percent From 2011 to 2015 drugs
August 08, 2019
Spending associated with essential medicines grew substantially from 2011 to 2015 for Medicare Part D beneficiaries, according to a study published online in The BMJ.
Liposomal medicine names to be changed to avoid errors europeanpharmaceuticalreview
August 07, 2019
The EMA has requested that liposomal medication names be changed to avoid the risk of confusion.

Previous page 1 2 3 4 5 6 7 8 9 Next page